Cited by 257Schizophrenia research and treatmentCannabis and Cannabinoid ResearchPsychopathy, Forensic Psychiatry, Sexual Offending

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: Follow-up study of 535 incident cases

Open access
Arendt, Mikkel, Rosenberg, Raben, Foldager, Leslie, Perto, Gurli, Munk-Jørgensen, Povl·2005·British Journal of Psychiatry

Abstract

BACKGROUND: Few studies have examined samples of people with cannabis-induced psychotic symptoms. AIMS: To establish whether cannabis-induced psychotic disorders are followed by development of persistent psychotic conditions, and the timing of their onset. METHOD: Data on patients treated for cannabis-induced psychotic symptoms between 1994 and 1999 were extracted from the Danish Psychiatric Central Register. Those previously treated for any psychotic symptoms were excluded. The remaining 535 patients were followed for at least 3 years. In a separate analysis, the sample was compared with people referred for schizophrenia-spectrum disorders for the first time, but who had no history of cannabis-induced psychosis. RESULTS: Schizophrenia-spectrum disorders were diagnosed in 44.5% of the sample. New psychotic episodes of any type were diagnosed in 77.2%. Male gender and young age were associated with increased risk. Development of schizophrenia-spectrum disorders was often delayed, and 47.1% of patients received a diagnosis more than a year after seeking treatment for a cannabis-induced psychosis. The patients developed schizophrenia at an earlier age than people in the comparison group (males, 24.6 v. 30.7 years, females, 28.9 v. 33.1 years). CONCLUSIONS: Cannabis-induced psychotic disorders are of great clinical and prognostic importance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1192/bjp.187.6.510

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is no robust evidence of clinical characteristics that allow the distinction of cannabis-induced psychotic disorder to be made.

    “Nor do we review case-studies or studies relying on a diagnosis of cannabis-induced psychotic disorder, as such diagnoses are dependent on assumptions of a causal role of cannabis in specific cases by a clinician, and there is no robust evidence as far as we are aware of clinical characteristics that allow the distinction of this disorder to be made (3).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jørgensen, P.
Affiliations
Aarhus University Hospital (DK)
Corresponding author
Arendt, Mikkel
Venue
British Journal of Psychiatry
Published
2005-12
Volume
187
Issue
6
Pages
510-515
ISSN
  • 0007-1250 (ISSN-L)
  • 1472-1465
OpenAlex
W2155659950
Cited by
257
References
35
Citations by year
2026: 10 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 12 · 2021: 6 · 2020: 10 · 2019: 9 · 2018: 12 · 2017: 14 · 2016: 13 · 2015: 13 · 2014: 11 · 2013: 13 · 2012: 18
FWCI
7.22
Type
journal article
Language
en
Open access
Locations
  • The British Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
Keywords
cannabis-induced psychosis, schizophrenia spectrum disorders, cannabis use, age of onset, gender differences, risk factors, prognosis
MeSH terms
Adult, Age Factors, Cannabis, Marijuana Abuse, Denmark, Female, Follow-Up Studies, Humans, Male, Psychotic Disorders, Recurrence, Risk Factors, Schizophrenia, Sex Factors, Incidence, Age of Onset

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review